The Swiss Competition Commission Are Coming! Novartis Dawn Raid shows clash between patent exclusivity and anti-competitive behaviours Posted on 7 February 2023
Novartis signs Voluntary License Agreement with the Medicine Patent Pool for Nilotinib Posted on 25 November 2022
